Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Romiplostim N01”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT07523009
What this trial is testing

CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA

Who this might be right for
Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06613880
What this trial is testing

Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

Who this might be right for
Aplastic AnemiaTPO Receptor Agonists
Institute of Hematology & Blood Diseases Hospital, China 48
Large-scale testing (Phase 3)Looking for participantsNCT06759636
What this trial is testing

A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Who this might be right for
CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771881
What this trial is testing

Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer

Who this might be right for
Thrombocytopenia Chemotherapy Induced
Fudan University 53
Testing effectiveness (Phase 2)Looking for participantsNCT06693791
What this trial is testing

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

Who this might be right for
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400250
What this trial is testing

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Peking Union Medical College Hospital 28
Not applicableNot Yet RecruitingNCT07185893
What this trial is testing

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Who this might be right for
Solid Tumor Malignancies, CancerCTIT-Chemotherapy Induced ThrombocytopeniaThrombocytopenia
Jun wang 106